insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 $
arrow_downward
-4,09%(-0,070) 1D
1,66 $
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
The Motley Fool
·
3 ժամ առաջ
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
TradingKey
·
8 ժամ առաջ
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
17 ժամ առաջ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
JournalArta
·
55 րոպե առաջ
S&P 500 Falls as AI Spending Fears Weigh on Stocks
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc